Your search for ganciclovir returned 21 results

Longer therapy with oral valganciclovir may modestly improve long-term developmental outcomes and hearing in neonates with symptomatic congenital cytomegalovirus (CMV) disease, reports a study in the New England Journal of Medicine.

For patients with glioblastoma, treatment with valganciclovir is associated with improved survival.

The NDA submission is supported by data from the multicenter, randomized, open-label, active-controlled phase 3 TAK-620-303 (SOLSTICE) trial.

Foscarnet sodium injection is indicated to treat cytomegalovirus retinitis in patients with AIDS and acyclovir-resistant mucocutaneous HSV in immunocompromised patients.

Viracta Therapeutics announced that the FDA has granted Orphan Drug designation to nanatinostat (VRx-3996), in combination with valganciclovir, for the treatment of post-transplant lymphoproliferative disorder.

Cytovene-IV is a deoxynucleoside analogue cytomegalovirus (CMV) DNA polymerase inhibitor.

Options include acyclovir, valacyclovir, topical ganciclovir; need for development of new compounds

Criteria for diagnosing myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) as well as treatment options are addressed in two systematic evidence reviews published in the Annals of Internal Medicine.

The Food and Drug Administration (FDA) has approved labeling updates for Valcyte (valganciclovir; Roche) tablets and oral solution to include expanded pediatric indication and dosage sections.

For liver transplant recipients, universal prophylaxis and preemptive strategies (using ganciclovir or valganciclovir) are similarly effective for preventing cytomegalovirus (CMV) disease (CMD).